CSIMarket


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Genetic Technologies Limited

GENE's Fundamental analysis








Genetic Technologies Limited's sales fell by -86.56 % in IV. Quarter 2019 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.17 %



More on GENE's Growth


Genetic Technologies Limited
reported net loss of -6 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.


More on GENE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Genetic Technologies Limited
reported net loss of -6 millions in the past twelve months.

Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.